208 related articles for article (PubMed ID: 36347025)
1. Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis.
Su Z; Xu L; Dai X; Zhu M; Chen X; Li Y; Li J; Ge R; Cheng B; Wang Y
Aging (Albany NY); 2022 Nov; 14(21):8818-8838. PubMed ID: 36347025
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
Front Oncol; 2020; 10():769. PubMed ID: 32582536
[No Abstract] [Full Text] [Related]
5. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
Kong F; Wang K; Wang L
Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
[TBL] [Abstract][Full Text] [Related]
7. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
Paramasivam A; George R; Priyadharsini JV
Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
[TBL] [Abstract][Full Text] [Related]
8. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
J Clin Lab Anal; ; . PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]